Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
Toxo 2024
Programm
Poster
Personen
Suche
DE
Poster zum Thema "Metabolism, Biochemistry & Drug Development"
Zurück
P003
The Role of Purine Auxotrophy in Toxoplasma-Host Interaction
Dr. Bruno Martorelli Di Genova (Burlington, VT / US)
P010
Anti-Apicomplexa drug discovery: Chemotherapeutic drug screening and target deconvolution in
Toxoplasma gondii
.
Dr. Laurence Braun (La Tronche / FR)
Alexandre Bougdour (La Tronche / FR)
P012
Structural insight into the apicomplexan drug target cytochrome
bc
1
Dr. Andrew Maclean (Glasgow / GB)
P014
Establishment of an
E. coli
model for studying the interaction and flexibility of apicoplast resident ferredoxin and bacterial flavodoxin redox systems towards IspH of the isoprenoid pathway
Ojo-Ajogu Akuh (Berlin / DE; Canberra / AU)
P015
Deciphering the transport of heme intermediates in
Toxoplasma gondii:
Insights from comparative genome wide CRISPR screens
Dr. Estefania Delgado Betancourt (Geneva / CH)
P022
Cross linking mass spectrometry: A new tool for studies on the
Toxoplasma gondii
protein interactome
Dr. Tadikimi Tomita (Bronx, NY / US)
P026
Critical roles of an oxysterol-binding protein in lipid synthesis and trafficking in
Toxoplasma gondii
Qin Biyun (Wuhan / CN)
P036
Activity and efficacy of the bumped kinase inhibitor BKI-1708
in vitro
and in non-pregnant and pregnant toxoplasmosis and neosporosis mouse models
Maria Ferreira de Sousa (Bern / CH)
P038
TgGloL is an atypical glyoxalase domain-containing apicoplast protein that is important for the growth of Toxoplasma
Dr. Sébastien Besteiro (Montpellier / FR)
P046
In vitro
evaluation of natural compounds extracts from
Tabebuia
against
Toxoplasma gondii
proliferation
Professor Jorge Enrique Gómez Marin (Armenia / CO)
P047
Treatment with BKI-1748 after
Toxoplasma gondii
systemic dissemination in experimentally infected sheep significantly improves clinical outcome and prevents congenital infection
Dr. Roberto Sánchez Sánchez (Madrid / ES)
P056
Comparative proteomic analysis of
Toxoplasma gondii Me49
-derived strains adapted to
in vitro
treatments with thiosemicarbazones
Manuela Semeraro (Parma / IT)
P064
Innovative Assay Development and Targeted Screening Unveil Compounds Against
Toxoplasma gondii
Bradyzoite and Tachyzoite Forms
Taher Uddin (St. Louis, MO / US)
P068
Evaluation of the Trithiolato-Bridged Arene Ruthenium Complex Conjugated to 9-(2-hydroxyethyl)-Adenine (OD62-18) as a Potential Treatment for
Toxoplasma gondii
Infection.
Kai Pascal Alexander Hänggeli (Bern / CH)
P069
Commercial kitten moist food inactivated
Toxoplasma gondii
tissue cysts instantaneously
Professor Andreas Lazaros Chryssafidis (Lages / BR)
P074
MQ-1: A Promising Marinoquinoline Derivative Demonstrating Effectiveness in Treating Acute and Chronic Toxoplasmosis in Murine Models
Professor Juliana Quero Reimão (Jundiaí / BR)
P078
Elucidating the role of a mitochondrial superoxide dismutase in
Toxoplasma gondii
Dr. Rosa Andrade (Irvine, CA / US)
P097
2,3-dihydro-1,4-benzodioxins are potent inhibitors of
T. gondii
tachyzoite regrowth
in vitro
Dr. P. Holland Alday (Portland, OR / US)
P099
Biochemical and Molecular Elucidation of Hydroquinine Mechanism(s) of Action against
T. gondii
Professor Daniel A. Abugri (Montgomery, AL / US)
P101
RNA triphosphatase-mediated mRNA capping is essential for maintaining transcriptome homeostasis and the survival of
Toxoplasma gondii
Kalyani Aswale (Hyderabad / IN)
P104
Reinvention of the diagnostic algorithm and treatment options for reactivated toxoplasmosis – ToxoReTREAT project
Dr. Tijana Štajner (Belgrade / RS)
P108
Searching for a vaccine against toxoplasmosis
Carina Brito (Porto / PT)
P112
Compounds From the MMV Pathogen Box Target
Toxoplasma gondii
Tachyzoites and Bradyzoites: Insights into Metabolic Responses and the Role of the
bc
1
-Complex in Bradyzoites
Deborah Maus (Berlin / DE)
P114
The myxobacterial compound Argyrin D inhibits protein translation in the mitochondria of
Toxoplasma gondii
and arrests tachyzoites and bradyzoites.
Janina Jocks (Berlin / DE)
P116
Differential Gene Expression of Toxoplasma gondii ME49 and RH Strains during ELQ-316 Inhibition
Jon deVries (Portland, OR / US)
P121
In Vitro Activity of Fractionated Methanoic Blueberry Extract against
Toxoplasma gondii
growth
Japhet Senyo Kamasah (Montgomery, AL / US)
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz